Research Institute of Molecular Pathology

The Research Institute of Molecular Pathology (IMP) is a basic biomedical research center sponsored largely by the pharmaceutical company Boehringer Ingelheim, and located in the Campus Vienna Biocenter (VBC). The IMP's primary goal is to conduct innovative basic research in the molecular life sciences. Over the years, the IMP has rapidly established a strong international reputation, reflected in the numerous national and international awards bestowed upon its scientists, and the many key research papers published in top-ranking scientific journals each year. The IMP attracts researchers from all over the world, almost all of whom move on after several years to leading scientific positions elsewhere in Austria or abroad. This constant turnover gives the IMP a young, dynamic and international spirit, and the flexibility to continually hire promising new scientific talents and expand its research activities into exciting new directions. Researchers at the IMP are committed to basic science, striving to unlock life's fundamental mysteries at the molecular and cellular levels.

Address
Campus-Vienna-Biocenter 1
Website
https://www.imp.ac.at

Subscribe to rss feed

Archaeology

Archaeologists discover remains of 9 Neanderthals near Rome

Italian archaeologists have uncovered the fossilized remains of nine Neanderthals in a cave near Rome, shedding new light on how the Italian peninsula was populated and under what environmental conditions.

Planetary Sciences

Ingenuity Mars helicopter completes first one-way trip

NASA's Ingenuity Mars Helicopter completed its fifth flight on the Red Planet today with its first one-way journey from Wright Brothers Field to an airfield 423 feet (129 meters) to the south. After arrival above its new ...

Security

Major US pipeline targeted in cyber attack

The largest fuel pipeline system in the United States was forced to shut down its entire network after a cyber attack, the company said in a statement.

Space Exploration

Chinese rocket to tumble back to Earth in uncontrolled re-entry

A large segment of a Chinese rocket is expected to make an uncontrolled re-entry into the Earth's atmosphere over the weekend, but Beijing has downplayed fears of damage on the ground and said the risk is very low.

Diseases, Conditions, Syndromes

Variant accelerating India's COVID explosion: WHO top scientist

A COVID-19 variant spreading in India is more contagious and may be dodging vaccine protections, contributing to the country's explosive outbreak, the World Health Organization's chief scientist said Saturday.

Vaccination

Merkel urges US to export COVID vaccines

German Chancellor Angela Merkel on Saturday urged the United States to export coronavirus vaccines made on its soil, as she rejected a patent waiver call from Washington for the jabs.